NEUP (Neuphoria Therapeutics Inc.) Stock Market Reviews

crown

search

Read and share opinions on NEUP (Neuphoria Therapeutics Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar

NEUP

Neuphoria Therapeutics Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value
Nov 11, 2025
Is Neuphoria Therapeutics Inc. (NASDAQ:NEUP) Worth US$4.4 Based On Its Intrinsic Value?
Oct 31, 2025
Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process
Oct 27, 2025
Neuphoria Says Phase 3 Trial of BNC210 to Treat Social Anxiety Disorder Did Not Meet Primary Endpoint
Oct 20, 2025
Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder
Oct 20, 2025
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates
Sep 29, 2025
Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder (SAD)
Sep 4, 2025
Neuphoria Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Aug 28, 2025
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
May 27, 2025
Neuphoria Provides First Quarter 2025 Business Updates
May 20, 2025
Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025
Mar 3, 2025
Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck
Feb 12, 2025
Bionomics Strategic Shift with Neuphoria Redomiciliation
Dec 24, 2024

Reviews